ALS-008176
ALS-008176 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
2
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model
A Study of ALS-008176 in Infants Hospitalized With RSV
Study to Evaluate the Effect of ALS-008176 on Cardiac Repolarization Interval in Healthy Participants
A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-008176
Clinical Trials (6)
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model
A Study of ALS-008176 in Infants Hospitalized With RSV
Study to Evaluate the Effect of ALS-008176 on Cardiac Repolarization Interval in Healthy Participants
A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-008176
Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6